Agilon Health had its Relative Strength (RS) Rating upgraded from 79 to 91 Monday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's proprietary RS Rating identifies technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the best stocks tend to have an RS Rating north of 80 at the beginning of a new climb.
Looking For Winning Stocks? Try This Simple Routine
Agilon Health is working through a consolidation, with a 28.15 buy point. Volume has increased recently as it moves upward. See if the stock can indeed break out in heavy volume.
Agilon Health stock saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 0% to 133%. Revenue rose from 44% to 58%. The company is expected to report its latest performance numbers on or around Aug. 4.
Agilon Health earns the No. 5 rank among its peers in the Commercial Services-Healthcare industry group. Premier and Corvel are among the top 5 highly rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
